Germany· DE-A57-48aa4c5019e7dff6
Multihance
A medicinal product containing gadobenate dimeglumine, registered in Germany by Bracco Imaging Deutschland Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Gadobenate Dimeglumine
- Manufacturer
- Bracco Imaging Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadobenate dimeglumine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMULTIHANCEBracco Imaging Deutschland GmbH, Konstanz
- BelgiumMultihance 0.5 mmol/mlBracco Imaging Deutschland
- United KingdomMultiHance 0.5mmol/ml solution for injection 10ml vialsBracco UK Ltd
- IrelandMultiHance 529 mg/ml solution for injection in pre-filled syringeBracco Imaging spa
- FranceMULTIHANCE 0,5 mmol/mL, solution injectable (IV)BRACCO IMAGING FRANCE
- SwedenMultiHance 334 mg/ml Injektionsvätska, lösningBracco Imaging SpA
- United StatesMultiHanceBRACCO DIAGNOSTICS INC
- NorwayMultiHanceBracco Imaging SpA
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Multihance
- Belgium · Multihance
- Czechia · Multihance
- Denmark · Multihance
- Spain · Multihance
- Finland · Multihance
- France · Multihance
- United Kingdom (Northern Ireland) · Multihance
- Greece · Multihance
- Croatia · Multihance
- Hungary · Multihance
- Ireland · Multihance
- Italy · Multihance
- Luxembourg · Multihance
- Netherlands · Multihance
- Norway · Multihance
- Poland · Multihance
- Portugal · Multihance
- Romania · Multihance
- Sweden · Multihance
- Slovenia · Multihance
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e10d69a-e2b4-4468-89f7-b97cd27e7b9e GET /v1/drugs/8e10d69a-e2b4-4468-89f7-b97cd27e7b9e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Gadobenate Dimeglumine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about gadobenate dimeglumine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.